Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
AQST: Aquestive Therapeutics, Inc. Stock Analysis | finqOS
Healthcare · Drug Manufacturers - Specialty & Generic
The Story
AQST
The Story
AQST
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
+13.8% / yr
Operating margin
-111.2%
ROIC
-44.8%
Financially safe
Stretched
Debt / equity
-3.92×
Interest coverage
-3.3×
Current ratio
4.10×
Aquestive Therapeutics, Inc.
AQST
NASDAQ Global Market
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Aquestive Therapeutics, Inc.
AQST
NASDAQ
·
USD
·
Closed
$3.69
−0.67%
$3.69
−$0.03 (0.67%)
52W Range
17th
pctl
Volume
0.90×
avg
Mkt Cap
463.60M
USD
P/E
-6.1
TTM
Div Yield
–
ann
52W Range
17th
pctl
Volume
0.90×
avg
Market Cap
463.60M
USD
P/E Ratio
-6.1
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings